Q-Cell Glioblastoma Resource: Proteomics Analysis Reveals Unique Cell-States Are Maintained in 3D Culture
Glioblastoma (GBM) is a treatment-refractory central nervous system (CNS) tumour, and better therapies to treat this aggressive disease are urgently needed. Primary GBM models that represent the true disease state are essential to better understand disease biology and for accurate preclinical therap...
Main Authors: | Rochelle C. J. D’Souza, Carolin Offenhäuser, Jasmin Straube, Ulrich Baumgartner, Anja Kordowski, Yuchen Li, Brett W. Stringer, Hamish Alexander, Zarnie Lwin, Po-Ling Inglis, Rosalind L. Jeffree, Terrance G. Johns, Andrew W. Boyd, Bryan W. Day |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-01-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/2/267 |
Similar Items
-
Editorial: GBM stem cells and the brain tumor microenvironment
by: Yunqing Li, et al.
Published: (2023-02-01) -
Aptamer-Based In Vivo Therapeutic Targeting of Glioblastoma
by: Valeriana Cesarini, et al.
Published: (2020-09-01) -
Inhibition of Carbonic Anhydrase 2 Overcomes Temozolomide Resistance in Glioblastoma Cells
by: Kai Zhao, et al.
Published: (2021-12-01) -
Identification of <i>SERPINE1</i> as a Regulator of Glioblastoma Cell Dispersal with Transcriptome Profiling
by: Fidan Seker, et al.
Published: (2019-10-01) -
Activation of ERBB4 in Glioblastoma Can Contribute to Increased Tumorigenicity and Influence Therapeutic Response
by: Jacqueline F. Donoghue, et al.
Published: (2018-07-01)